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Abstract: Piceatannol (E-3,5,3’,4’-tetrahydroxystilbene) is a phytoalexin synthesized in 
grapes in response to stress conditions. It exhibits strong antioxidant and antileukaemic 
activities due to the presence of the catechol moiety. To modify some physical properties 
like solubility, and miscibility in non-aqueous media some new previously unreported 
piceatannol derivatives having lipophilic chains on the A-ring were prepared in good 
yields by a simple and efficient procedure. The key step was a chemo- and regioselective 
aromatic hydroxylation with 2-iodoxybenzoic acid (IBX). The new compounds showed 
antioxidant activity and seemed promising for possible applications as multifunctional 
emulsifiers in food, cosmetic and pharmaceutical fields. 
Keywords: aromatic hydroxylation; 2-iodoxybenzoic acid (IBX); lipophilic piceatannol 
derivatives; lipophilic antioxidants 
 
1. Introduction 
In the last few years, stilbene-based compounds have attracted the attention of many researchers 
due to their wide range of positive biological effects [1–3]. One of the most relevant and extensively 
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studied compounds is resveratrol (E-3,5,4’-trihydroxystilbene 1, Figure 1), a phenolic compound 
found mainly in grapes, where it is synthesized in response to stress conditions such as fungal infection 
and trauma [4–5]. In red wines it is present at concentrations of mg/L and it is well known that a 
moderate alcohol consumption has some protective effects against coronary heart disease [6]. Several 
studies have demonstrated that resveratrol exhibits a wide range of biological and pharmacological 
activities [7–8]. For example, it has been shown to have cancer preventive properties [9–11], anti-
inflammatory activities [12], and a role in the prevention of atherosclerosis and coronary diseases  
[13–14]. 
Figure 1. Chemical structure of natural stilbenes 1 and 2. 
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Structurally similar to resveratrol is piceatannol (E-3,5,3’,4’-tetrahydroxystilbene 2) which differs 
from 1 in that it possesses an extra hydroxyl group adjacent to the active 4’-OH of resveratrol. It is 
present in low quantity in grapes [15], peanuts [16], Euphorbia lagascae [17] and Vaccinium berries 
[18] and, like resveratrol, it is a phytoalexin. Piceatannol (2) shows many biological activities [19–21]. 
It has known anticancer and antileukaemic properties, inducing apoptosis in several cell lines and 
animal models; it inhibits a variety of tyrosinase kinases involved in cell proliferation [22–23]. A 
recent study has demonstrated that the cancer preventative properties of resveratrol (1) are related to 
its natural conversion into metabolite piceatannol (2) in living cells by the enzyme CYP1B1 (belongs 
to the cytochrome P450 enzyme family) that is over-expressed in a wide variety of human tumors [24]. 
Other experimental evidences showed that piceatannol has a higher level of antioxidant activity 
compared to resveratrol [25]. This result is according to the evidence that a catechol moiety present in 
a compound increases the cytotoxic and antioxidant activity in vitro [26–27].  
As all naturally occurring phenolic antioxidants, stilbene derivatives 1 and 2 are hydrophilic and 
thus scarcely soluble in aprotic solvents, oils and emulsions. Consequently, their application in the 
food, pharmaceutical and cosmetic fields is strongly limited.  
In recent times, more attention has been turned on the development of possible strategies to modify 
and to enhance the functional properties of natural antioxidants without altering the functionality 
responsible for the biological activities. For example, the hydrophobicity of antioxidant phenolic acids 
has been enhanced by esterifying the carboxylic acid moiety of the phenolic acid with a fatty alcohol 
by chemical and enzymatic procedures [28]. In a similar way, phenethyl alcohols have been 
lipophilized by esterifying the alcoholic function with acid chlorides or acid anhydrides [29]. In this 
way amphiphilic phenolic compounds that are able to distribute between the aqueous phase and the 
lipophilic phase and interact with an emulsifier at the interface were obtained. Recently, it has been 
reported that these compounds are potentially interesting for possible applications in nanotechnology 
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[30]. To the best of our knowledge, lipophilic piceatannol derivatives have not been reported in the 
literature and no chemical or enzymatic synthetic procedures are described.  
In the last few years, our research has been devoted to the preparation of biologically active 
catecholic compounds from naturally occurring phenols by oxidative procedures. For example, we 
obtained in very good yields 2-(3’,4’-dihydroxyphenyl)ethanol (hydroxytyrosol) and its lipophilic 
derivatives, useful molecules for cosmetic and pharmaceutical applications [31–35]; novel lignans 
showing antioxidant activity [36]; endogenous catecholamines utilized for the treatment of many 
clinical disorders, including hypertension and cardiovascular diseases [37]. The oxidant of choice was 
1-hydroxy-1-oxo-1H-1λ5-benzo[d][1,2]iodoxol-3-one (2-iodobenzoic acid, IBX, Figure 2), the most 
important representative of pentavalent iodine heterocycles first prepared by Hartmann and Mayer [38] 
which has attracted increasing interest during the last decade because of its selective, mild and 
environmentally friendly properties as an oxidant in organic synthesis [39-41]. Among its synthethic 
potential, it is particularly interesting the ability to perform a regioselective oxidation of phenols into 
ortho-quinones [42-44]. When the oxidative step was followed by in situ reduction, a catechol moiety 
was produced with a selectivity similar to that of cytochrome P450 enzymes [45]. 
Figure 2. Chemical structure of 2-iodoxybenzoic acid (IBX). 
 
 
In this paper we describe a simple and efficient route to prepare lipophilic piceatannol derivatives 
displaying free-catecholic functionality in the B ring and long alkyl chains in the A ring by an 
oxidative procedure using IBX and subsequent reduction with sodium dithionite (Na2S2O4). As 
examples of chains with different length, we choose acetyl (C2), butanoyl (C4), octanoyl (C8) and 
palmitoyl (C16). These new compounds were then evaluated for their radical-scavenging activity using 
the DPPH method [46]. 
2. Results and Discussion 
2.1. Preparation of 3,5-di-O-acyl resveratrol derivatives 4a-d 
Firstly, we prepared 3,5-di-O-acyl resveratrol derivatives 4a-d by a two-step procedure (Scheme 1). 
Peracylated derivatives [3,5,4’-tri-O-acetyl resveratrol (3a); 3,5,4’-tri-O-butanoyl resveratrol (3b); 
3,5,4’-tri-O-octanoyl resveratrol (3c) and 3,5,4’-tri-O-palmitoyl resveratrol (3d)] were obtained in  
90–95% yields from resveratrol (1) using acetic and butyric anhydride in pyridine and octanoyl and 
palmitoyl chloride in pyridine, respectively (step a); then, compounds 3a-d were dispersed in t-butyl 
methyl ether and n-butanol and subjected to enzymatic alcoholysis with Candida antarctica lipase to 
isolate the corresponding 3,5-di-O-acetylated resveratrol derivatives 4a-d in 60–90% yields (step b) 
[47–48]. 
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Scheme 1. Synthesis of 3,5-di-O-acetylresveratrol derivatives 4a-d. 
 
2.2. Aromatic hydroxylation of compounds 4a-d 
The key reaction for the preparation of 3,5-di-O-acyl piceatannol derivatives 5a-d was the insertion 
of an hydroxyl group in C-3’ (B ring) of compounds 4a-d (Scheme 2). The model substrate for the 
optimization of the reaction conditions was 3,5-di-O-acetyl resveratrol (4a). 
Scheme 2. Aromatic hydroxylation of 3,5-di-O-acyl resveratrol derivatives 4a-d. 
OCOR
ROCO
OH
4'
4a-d
OCOR
ROCO
OH
4'
5a-d
OH
3'
IBX-oxidative procedure
a: R=CH3
b: R=(CH2)2CH3
c: R=(CH2)6CH3
d: R=(CH2)16CH3
Na2S2O4-reduction
 
 
We performed some experiments varying the solvent, reaction time, and temperature (Table 1). In 
all cases an excess of IBX was used (1.2 equiv.); Na2S2O4 in tetrahydrofuran (1.0 M) was the reducing 
solution. Reactions were monitored by chromatographic analysis (TLC and HPLC). On the basis of the 
literature data [49], first we used methanol as solvent and a low temperature reaction but under these 
experimental conditions 3,5-di-O-acetyl piceatannol (5a) was isolated in low yield (Table 1, entry 1). 
The best result in terms of solubility, conversion and yield was obtained by dissolving compound 4a in 
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dimethyl sulfoxide (DMSO) at room temperature. In these experimental conditions, piceatannol 
derivative 5a was isolated in quantitative yield after only 1 h (Table 1, entry 4). The oxidative step was 
both chemoselective and regioselective the double bond present of 5a being unaffected.  
Table 1. Aromatic hydroxylation of 3,5-di-O-acetyl resveratrol (4a) with IBX/Na2S2O4 procedure. 
Entry Solvent T (°C) Time (h) Conv. (%) Yield of 5a (%) 
1 Methanol 0 1 20 20 
2 Methanol/Chloroform=1/1 0 1 70 68 
3 Dimethyl carbonate 25 2 50 46 
4 Dimethyl sulfoxide 25 1 >98 95 
 
A significative region of the 13C-NMR spectrum of the new synthesized 3,5-di-O-acetyl piceatannol 
(5a) is shown in Figure 4. The presence of the catecholic moiety in the B-ring of 3,5-di-O-acetyl 
piceatannol (5a) was confirmed by analyzing this spectroscopic region, which showed the lack of 
symmetry of the B-ring, two quaternary carbon atoms (C-3’ and C-4’) at 140.4 and 144.2 ppm and 
three C-H carbons (C-2’, C-5’, C-5’) at 113.5, 115.3 and 116.8 ppm, respectively. 
Figure 4. 13C-NMR spectrum (180-110 ppm region) of 3,5-di-O-acetyl piceatannol (5a). 
  
 
Furthermore, the presence of two free hydroxyl groups in 5a was chemically demonstrated by an 
esterification reaction of 5a under classical conditions with acetic anhydride in pyridine (Scheme 3). 
As expected, the proton magnetic resonance spectrum (1H-NMR) of the resulting product 6a 
evidenced the presence of two singlets at 2.23 and 2.25 ppm attributable to the twelve protons of the 
four acetyl groups of 6a.  
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Scheme 3. Acetylation of 3,5-di-O-acyl piceatannol derivative 4a. 
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As already reported, a plausible ionic mechanism for the regioselective aromatic hydroxylation of 
phenol derivatives was reported by Pettus et al. [42]. The phenol added to the iodine-(V) center of IBX 
to give a λ5-iodanyl intermediate and to extrude H2O. The intramolecular (and regioselective) delivery 
of an oxygen atom from this specie lead to a λ3-iodanyl intermediate which undergoes tautomerization 
and oxidatively collapses to produce an ortho-quinone derivative and 2-iodobenzoic acid (IBA), the 
only by-product of the reaction. The catecholic moiety was finally obtained after the in situ  
reductive step. 
On the basis of the good results, this simple efficient and useful synthetic procedure was applied to 
3,5,4’-tri-O-butanoyl resveratrol (4b); 3,5,4’-tri-O-octanoyl resveratrol (4c) and 3,5,4’-tri-O-palmitoyl 
resveratrol (4d) (Scheme 2). The corresponding lipophilic piceatannol derivatives 5b-d were isolated 
in satisfactory yields (Table 2, entry 1-3) and with a high degree of purity. 
Table 2. Aromatic hydroxylation of resveratrol derivatives 4a-d with IBX/Na2S2O4 procedure. a 
Entry Substrate Time (h) Conv. (%) Yield (%) 
1 4b 1 92 5b: 88 
2 4c 2 90 5c: 84 
3 4d 2 90 5d: 82 
a Oxidation reactions were performed in DMSO at room temperature. 
2.3. Evaluation of the antioxidant activity of 5a-d 
After their preparation, we evaluated the radical scavenging activity of compounds 5a-d using the 
stable 2,2-diphenyl-1-picrylhydrazyl (DPPH•) radical commonly and widely utilized for testing this 
activity in natural phenolic compounds. Experimental results are reported in Table 3 and Figure 5. The 
parameter SC50 is the Scavenging Capacity that is the concentration of compound (expressed in μM) 
able to quench the 50% of DPPH radical in a 184 μM solution (see Experimental section for details). 
As shown, SC50 values of lipophilic derivatives 5a-d were in the range 28.9–35.6 μM. All tested 
compounds exhibited an antioxidant activity superior to that of resveratrol 1 and comparable to that of 
piceatannol 2 [50]. The length of the alkyl chain does not influence the radical-scavenging activity.  
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Figure 5. DPPH• scavenging activity of compounds 5a-d expressed as 100/SC50. 
 
Table 3. DPPH• scavenging activity of compounds 5a-d expressed as SC50. 
Compound SC50 (μM)a ± SD 
5a 35.6 ± 2.1 
5b 32.2 ± 2.5 
5c 30.0 ± 1.6 
5d 28.9 ± 1.4 
a Each reported value is the mean of three separate measurements. 
3. Experimental 
3.1. Materials and methods 
Resveratrol was purchased from Aldrich Company (Milan, Italy) as well all other solvents and 
reagents. All chemicals used were of analytical grade. IBX was prepared in our laboratory as described 
in the literature [51]. The Candida antarctica lipase (Chirazyme L-2, c. –f., C2, Lyo) was a gift from 
Roche. HPLC analyses were performed on a Varian Prostar 325 apparatus equipped with a Varian 
Pursuit 5μ C18 column (150 × 4.6 mm) and a dual wavelength UV-Vis detector selected on λ = 280 nm. 
Elutions were carried out at a 1 mL/min flow rate using a H2O/CH3CN mixture (90:10, v/v) for the 
first minute and a gradient to 40:60 within the following 30 minutes. 1H- and 13C-NMR spectra were 
recorded in CD3COCD3 or CDCl3/CD3OD using a Bruker 200 MHz spectrometer. All chemical shifts 
are expressed in parts per million (δ scale) and referenced to either the residual protons or carbon of 
the solvent. HRMS were recorded with Micromass Q-TOF Spectrometer (Waters). Compounds 4a-d 
were purified by flash chromatography on silica gel using the Buchi-Biotage FLASH 12™ system 
equipped with prepacked silica gel cartridges 12S. Analytical Thin-Layer Chromatography (TLC) 
were performed on silica gel (Merck 60 F254) plates using cerium sulphate as developing reagent.  
3.2. Preparation of 3,5-di-O-acyl piceatannol derivatives 5a-d 
Step a. Acylation reactions of resveratrol (1). Peracylated derivatives [3,5,4’-tri-O-acetylresveratrol 
(3a); 3,5,4’-tri-O-butanoylresveratrol (3b); 3,5,4’-tri-O-octanoylresveratrol (3c) and 3,5,4’-tri-O-
palmitoylresveratrol (3d)] were prepared using acetic and butyric anhydride in pyridine (1:1) and 
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octanoyl and palmitoyl chloride in pyridine (1:1), respectively. The solutions were stirred at room 
temperature for 6-12 h; then, they were acidified with HCl 2N and extracted with ethyl acetate; the 
organic layer was washed with a solution of NaHCO3, and dried with Na2SO4. The solvent was 
removed under reduced pressure to afford the peracylated derivatives 3a-d in 90-95% yields.  
 
Step b. Enzymatic alcoholysis of 3,5,4’-triO-acylresveratrol derivatives 3a-d. Compounds 3a-d  
(200 mg) were dispersed in t-butyl methyl ether (20 mL) and n-butanol (0.8 mL); Candida antarctica 
lipase (200 mg) was added to the solution of 3a-d and the mixture was shaken (400 rpm) at 40 °C. 
Finally, reactions were quenched by filtering off the enzyme and the filtrate was evaporated in vacuo. 
The residue was subjected to flash chromatography to obtain the di-O-acyl derivatives 4a-d in 60–90% 
yields. MS-FAB and 1H-NMR spectra of 3a-d and 4a-d were identical to those reported in the 
literature [47–48]. 
3.3. Aromatic hydroxylation of 3,5-di-O-acyl resveratrol derivatives 4a-d 
Compounds 4a-d (0.5 mmol) were dissolved in dimethyl solfoxide (5 mL) and then 2-iodoxy-
benzoic (IBX) was added (1.2 eq.). The mixture was kept under magnetic stirring at room temperature 
and monitorated by TLC. When the substrates disappeared, water (5 mL) and sodium dithionite (0.5 
mmol) were added. A chromatic change of the solution from red to colorless was observed. After  
5 minutes, the mixtures were extracted with ethyl acetate (3 × 10 mL). The organic phases were 
washed with a solution of NaHCO3and then dried on Na2SO4. The organic solvent was evaporated 
under reduced pressure obtaining a crude. Final products 5a-d were purified by chromatographic 
purification on silica gel and characterized by spectroscopic analysis.  
 
3,5-Di-O-acetylpiceatannol (5a). Colorless oil, quantitative yield. 1H-NMR (CD3COCD3) δ 2.27 (s, 
6H, 2 × CH3), 2.99 (2H, OH), 6.80-7.20 (m, 8H, CHα=CHβ, H-2,4,6,2’,5’,6’); 13C-NMR (CD3COCD3) 
δ 21.1, 113.1, 113.6, 115.3, 116.9, 120.1, 123.9, 129.7, 130.3, 140.4, 144.2 , 144.3, 151.2, 170.0; 
HRMS found: 328.22; C18H16O6 requires 328.09. 
3,5-Di-O-butanoyl piceatannol (5b). Yellow oil, 88% yield. 1H-NMR (CD3COCD3) δ 1.02 (t, 6H,  
J = 7.3 Hz, 2 × CH3), 1.65-1.83 (m, 4H, 2 × CH2CH3), 2.56 (t, J = 9.8 Hz, 4H, OCOCH2), 6.79-7.20 
(m, 8H, CHα=CHβ, H-2,4,6,2’,5’,6’); 13C-NMR (CD3COCD3) δ 13.7, 18.9, 36.4, 114.0, 114.9, 116.2, 
117.3, 120.3, 124.8, 130.1 , 131.5, 141.1, 146.1, 146.5, 152.6, 172.1; HRMS found: 384.34; C22H24O6 
requires 384.16. 
 
3,5-Di-O-octanoyl piceatannol (5c). Yellow oil, 84% yield. 1H-NMR (CD3COCD3) δ 0.86 (m, 6H, 2 × 
CH3), 1.28-1.42 (m, 16H, 8 × CH2), 1.62-1.76 (m, 4H, 2 × CH2), 2.56 (t, J = 7.2 Hz, 4H, 2 × CH2), 
6.75-7.15 (m, 8H, CHα=CHβ, H-2,4,6,2’,5’,6’); 13C-NMR (CD3COCD3) δ 14.2, 23.2, 25.5, 29.6, 29.7, 
32.3, 34.5, 114.0, 114.9, 116.2, 117.3, 120.3, 124.8, 130.1, 131.5, 141.0, 146.1, 146.5, 152.6, 172.1; 
HRMS found: 496.08; C30H40O6 requires 496.28. 
 
3,5-Di-O-palmitoyl piceatannol (5d). Yellow oil, 82% yield. 1H-NMR (CDCl3+CD3OD) δ 0.83 (m, 
6H, 2 × CH3), 1.12-1.38 (m, 48H, 24 × CH2), 1.66-1.73 (m, 4H, 2 × CH2), 2.50 (t, J = 7.3 Hz, 4H, 2 × 
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CH2), 6.68-7.01 (m, 8H, CHα=CHβ, H-2,4,6,2’,5’,6’); 13C-NMR (CDCl3+CD3OD) δ 14.0, 22.6, 24.8, 
29.1, 29.2, 29.3, 29.4, 29.6, 29.7, 31.9, 34.4, 112.7, 113.7, 115.1, 116.5, 119.8, 124.5, 129.5, 130.6, 
140.1, 144.5, 144.8, 151.3, 172.2; HRMS found: 720.21; C42H72O6 requires 720.53. 
3.4. Acetylation of 3,5-di-O-acetyl piceatannol (5a) 
Compound 5a (1.0 mmol) was solubilized in pyridine (10 mL) and acetic anhydride was added  
(10 mL) overnight. At the end of the reaction, a 1 M solution of HCl (10 mL) was added and the final 
product was extracted with ethyl acetate (3 × 10 mL). The combined organic phases were washed with 
a solution of NaHCO3 (20 mL) and with a saturated solution of NaCl (20 mL), then dried over Na2SO4. 
After evaporation of the solvent, and chromatographic purification on silica gel, 3,5,3’,4’-tetra-O-
acetyl piceatannol (6a) was isolated in quantitative yield and characterized by spectroscopic data. 
Colorless oil; 1H-NMR (CDCl3) δ 2.23 (s, 6H, 2 × CH3), 2.25 (s, 6H, 2 × CH3), 6.84 (t, J = 2.0 Hz, 1H, 
H-4), 6.96 (d, J = 16 Hz, 2H, CH=CHβ), 7.02 (d, J = 16 Hz, 2H, CHα=CH), 7.10 (d, J = 2.0 Hz, H-
2,6), 7.18 (d, J = 8.5 Hz, H-5’), 7.30 (d, J = 1.5 Hz, H-2’), 7.34 (dd, J = 8.5 and 1.5 Hz, H-6’). 13C-
NMR (CDCl3) δ 20.6, 21.1, 114.6, 117.0, 121.2, 123.6, 125. 0, 128.2, 128.8, 139.2, 141.7, 141.7, 
142.3, 151.3, 168.2, 168.9; HRMS found: 412.24; C18H16O6 requires 412.12. 
3.5. Measure of antioxidant activity of compounds 5a-d 
The radical scavenging activity of compounds 5a-d was evaluated in the presence of stable radical 
DPPH• according to the method of Brand-Williams et al. [46]. The initial concentration of DPPH• in 
acetone was controlled for every experiment from a calibration curve made by measuring the 
absorbance at λ = 517 nm of standard DPPH• solutions at different concentrations. The equation of the 
curve was ABS515nm = 10,865 × [DPPH•], as determined by linear regression. The compounds 5a-d 
were tested at three different concentrations and each concentration was analyzed in triplicate. In a 
typical procedure, 10, 20 and 30 μL of freshly prepared acetone solution of compounds 5a-d were 
added to 2 mL of freshly prepared 184 μM acetone solution of DPPH•. The solutions were shaken for 
30 min in the dark at 25 °C. The results were plotted as the percentage of reacted DPPH• [(ABS0h – 
ABS30min)/ABS0h × 100] vs the concentration (μM) of the added compounds 5a-d. The results were 
expressed as SC50 that is the concentration of compound required to quench 50% of the initial DPPH• 
radicals under the experimental conditions given. 
4. Conclusions 
In summary, we have described a simple and efficient procedure to prepare new piceatannol 
derivatives from naturally occurring resveratrol. These compounds possess a free-catecholic moiety in 
the B ring and long alkyl chains on the A ring. With these chemical features they exhibited an 
antioxidant activity similar to that of piceatannol, but a greater lipophilicity, therefore, they may be 
advatageously used as food antioxidants in bulk lipids or emulsions, and could be further evaluated for 
possible applications in the pharmaceutical, nutritional and cosmetic fields. 
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